Management of anti TB drug induced hepatitis
dc.contributor.author | Senaratne, W.V. | en_US |
dc.date.accessioned | 2013-11-27T06:31:03Z | |
dc.date.available | 2013-11-27T06:31:03Z | |
dc.date.issued | 2005 | en_US |
dc.identifier.citation | Journal of the Ceylon College of Physicians, 38(1):p.54-55 | en_US |
dc.identifier.uri | https://dl.nsf.gov.lk/handle/1/10124 | |
dc.publisher | The Ceylon College of Physicians. Rajagiriya | en_US |
dc.subject | Medical Sciences | en_US |
dc.subject | Tuberculosis | en_US |
dc.subject | Drug therapy | en_US |
dc.subject | Drug effects | en_US |
dc.subject | Drug induced hepatitis | en_US |
dc.subject | Diagnosis | en_US |
dc.subject | Disease management | en_US |
dc.title | Management of anti TB drug induced hepatitis | en_US |
dc.type | A | en_US |